Specific high-resolution scheme to improve understanding of the spatio-temporal dispersion of lymphogranuloma venereum epidemic.

Chlamydia trachomatis MLST lymphogranuloma venereum molecular epidemiology surveillance

Journal

Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977

Informations de publication

Date de publication:
2022
Historique:
received: 29 09 2022
accepted: 09 11 2022
entrez: 6 1 2023
pubmed: 7 1 2023
medline: 7 1 2023
Statut: epublish

Résumé

Lymphogranuloma venereum (LGV) is already endemic in vulnerable populations in several European countries; however, molecular epidemiology data with improved accuracy are necessary to better understand LGV epidemic in these countries. Current strategies to study the molecular epidemiology of LGV cases involve schemes based on a few genetic fragments of Four genes were selected according to their diversity index (CTLon_0054, CTLon_0087, CTLon_0243 and CTLon_0301) for use in combination with Our proposal demonstrated higher diversity allowing the identification of three main groups compared to the previously published MLST based on hypervariable genes wherein only a single sequence type was identified. The temporal analysis showed that the major cluster was progressively diversifying, revealing a very active transmission chain. Furthermore, an L2b genome identical to that of the origin of the epidemic was detected, suggesting reintroductions or a low screening rate in vulnerable populations. The spatial distribution suggests that the selection and spread of new variants occurs from the central district to the peripheral regions. The scheme proposed in this study has proven to be useful for appropriate discrimination of LGV strains. This study, to our knowledge for the first time, demonstrates a spatio-temporal spread that increases our understanding and identifies areas with special susceptibility for maintenance of the endemic situation of LGV.

Identifiants

pubmed: 36605505
doi: 10.3389/fmicb.2022.1056216
pmc: PMC9808035
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1056216

Informations de copyright

Copyright © 2022 Martínez-García, González-Alba, Puerta, Comunión, Rodríguez-Jiménez, Orviz, Sánchez-Conde, Rodríguez-Domínguez, Cantón and Galán.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Can Commun Dis Rep. 2015 Feb 05;41(2):20-25
pubmed: 29769927
Clin Microbiol Infect. 2008 Jul;14(7):644-52
pubmed: 18558936
Infect Drug Resist. 2015 Mar 27;8:39-47
pubmed: 25870512
Infect Immun. 1991 Apr;59(4):1579-82
pubmed: 1706325
J Clin Microbiol. 2007 May;45(5):1410-4
pubmed: 17329456
Curr Opin Infect Dis. 2015 Feb;28(1):61-71
pubmed: 25490105
Mol Biol Evol. 1993 May;10(3):512-26
pubmed: 8336541
PLoS One. 2021 Jul 8;16(7):e0254233
pubmed: 34237111
Sex Transm Infect. 2021 Sep;97(6):441-445
pubmed: 33106439
Euro Surveill. 2021 May;26(18):
pubmed: 33960288
Med J Aust. 2007 Sep 3;187(5):309-10
pubmed: 17767440
Clin Infect Dis. 2021 Aug 16;73(4):e1004-e1007
pubmed: 33512482
Enferm Infecc Microbiol Clin (Engl Ed). 2022 Nov;40(9):470-472
pubmed: 36336377
Int J Infect Dis. 2018 Oct;75:34-38
pubmed: 30125691
Euro Surveill. 2018 Oct;23(43):
pubmed: 30376912
Microb Genom. 2021 Jun;7(6):
pubmed: 34184981
Emerg Infect Dis. 2010 Nov;16(11):1777-9
pubmed: 21029543
Emerg Infect Dis. 2009 Sep;15(9):1385-94
pubmed: 19788805
Microb Genom. 2018 Feb;4(2):
pubmed: 29310749
Euro Surveill. 2020 Apr;25(14):
pubmed: 32290900
J Med Microbiol. 2017 Nov;66(11):1684-1687
pubmed: 29022544
Nat Genet. 2012 Mar 11;44(4):413-9, S1
pubmed: 22406642
J Clin Microbiol. 2011 Aug;49(8):2844-53
pubmed: 21653758
Sex Transm Infect. 2020 Mar;96(2):137-142
pubmed: 31235527
BMC Microbiol. 2008 Feb 28;8:42
pubmed: 18307777
Genome Res. 2008 Jan;18(1):161-71
pubmed: 18032721
Clin Microbiol Infect. 2014 Mar;20(3):219-25
pubmed: 23730727
Front Microbiol. 2018 Aug 22;9:1854
pubmed: 30186244
Front Cell Infect Microbiol. 2012 May 17;2:68
pubmed: 22919659
Clin Infect Dis. 2015 Dec 15;61 Suppl 8:S865-73
pubmed: 26602624
PLoS One. 2011 Feb 11;6(2):e16971
pubmed: 21347295
Sex Transm Infect. 2016 Jun;92(4):299-304
pubmed: 26487754

Auteurs

Laura Martínez-García (L)

Servicio de Microbiología, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

José María González-Alba (JM)

Servicio de Microbiología, Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.

Teresa Puerta (T)

Centro Sanitario Sandoval, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.

Alicia Comunión (A)

Centro Montesa, Madrid, Spain.

María Concepción Rodríguez-Jiménez (MC)

Servicio de Microbiología, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.

Eva Orviz (E)

Centro Sanitario Sandoval, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.

Matilde Sánchez-Conde (M)

Servicio de Enfermedades Infecciosas. Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.

Mario Rodríguez-Domínguez (M)

Servicio de Microbiología, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Rafael Cantón (R)

Servicio de Microbiología, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.

Juan Carlos Galán (JC)

Servicio de Microbiología, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Classifications MeSH